Boehringer Ingelheim launches first-of-a-kind fundraising model to support disease awareness projects
1 June 2012 | By Boehringer Ingelheim
Boehringer Ingelheim announces a new partnership with ammado...
List view / Grid view
News
Catalent enters agreement to sell its U.S. commercial packaging operations
31 May 2012 | By Catalent Pharma Solutions
Catalent signed a definitive agreement to sell its U.S. commercial packaging operations based in Philadelphia, PA and Woodstock, IL...
Phenomenex streamlines access to applications library with unique structure search capability
31 May 2012 | By Phenomenex
Phenomenex Inc., announces unique new Structure Search functionality...
Novartis showcases ongoing research at ASCO to help patients fight various cancers
31 May 2012 | By Novartis
Novartis will showcase the clinical progress of multiple marketed and pipeline compounds...
New data showed LIVALO® (pitavastatin) met primary endpoint of LDL-C reduction when compared with pravastatin
31 May 2012 | By Eli Lilly and Company
Results of the PREVAIL U.S. study...
Boehringer Ingelheim expands development capacities with new technical centre
31 May 2012 | By Boehringer Ingelheim
Boehringer Ingelheim is establishing a new 50 million-plus euro pilot plant facility...
GSK announces submissions in the EU & US for new indications for Promacta®/Revolade®
30 May 2012 | By GlaxoSmithKline
GlaxoSmithKline has submitted regulatory applications in the European Union and US...
Lilly’s commitment to global innovation reinforced with opening of new diabetes-focused research and development center in Shanghai
30 May 2012 | By Eli Lilly and Company
Eli Lilly & Company opened the LCRDC...
Biogen Idec continues support for MS community with worldwide celebrations on Fourth Annual World MS Day
30 May 2012 | By Biogen Idec
Biogen Idec will join with the MS community around the world...
Boehringer Ingelheim further strengthens animal health presence in China
30 May 2012 | By Boehringer Ingelheim
Boehringer Ingelheim and Taizhou China Medical City announced the signing of an agreement...
GlaxoSmithKline confirms US District Court ruling in Pronova BioPharma’s favour on Lovaza™ patents
29 May 2012 | By GlaxoSmithKline
GSK which has the marketing rights for Lovaza in the US and Puerto Rico...
GSK announces start of Phase III programme for combination of dabrafenib (GSK2118436) and trametinib (GSK1120212) in BRAF V600 mutation-positive metastatic cutaneous melanoma
29 May 2012 | By GlaxoSmithKline
GlaxoSmithKline plc. announced the start of a Phase III programme...
Lundbeck’s Lu AE58054 meets primary endpoint in large placebo-controlled clinical proof of concept study in people with Alzheimer’s disease
29 May 2012 | By H. Lundbeck A/S
The pivotal clinical programme is in planning...
Abbott to present wide range of investigational efficacy, safety and health outcomes data on HUMIRA®
29 May 2012 | By Abbott
Latest investigational research findings on HUMIRA®...
Sanofi inaugurates Lantus® SoloSTAR® pen assembly plant in its Beijing facility
28 May 2012 | By Sanofi
The group pledges continuous commitment to diabetes management in China...
